| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $9.0B | $9.2B | $9.6B | $2.5B | $2.5B | — |
| Cost of Revenue | $2.6B | $2.9B | $3.0B | $3.2B | $3.3B | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | $0.0B | $0.0B | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $-0.1B | $1.7B | $1.7B | $1.8B | $0.4B | $0.5B | $0.2B |
| Net Income | $-1.9B | $-0.1B | $0.1B | $0.2B | $0.0B | $0.2B | $2.3B |
| EPS (Basic) | $-4.00 | $-0.22 | $0.12 | $0.43 | $0.21 | — | $2.18 |
| EPS (Diluted) | $-4.00 | $-0.22 | $0.12 | $0.43 | $0.21 | — | $2.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $30.7B | $31.7B | $31.9B | $33.7B | $34.1B | $33.6B | $34.8B |
| Current Assets | $1.6B | $0.7B | $0.8B | $2.6B | $1.4B | $0.9B | $0.9B |
| Cash & Equivalents | $1.0B | $0.3B | $0.3B | $0.3B | $0.7B | $0.3B | $0.3B |
| Total Liabilities | $33.0B | $32.2B | $32.4B | $34.2B | $31.7B | $29.8B | $29.0B |
| Current Liabilities | $2.1B | $2.3B | $2.3B | $4.0B | $2.0B | $2.0B | $2.5B |
| Stockholders' Equity | $-2.3B | $-0.5B | $-0.4B | $-0.5B | $2.3B | $3.7B | $5.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.6B | $1.8B | $2.4B | $2.6B | $2.5B | $2.0B |
| Investing Cash Flow | $-1.3B | $-1.5B | $-1.7B | $-1.9B | $-1.5B | $-1.1B | $-1.1B |
| Capital Expenditures | $1.3B | $1.4B | $1.7B | $1.9B | $1.4B | $1.2B | $1.0B |
| Financing Cash Flow | $0.9B | $-0.2B | $-0.1B | $-0.3B | $-0.6B | $-1.4B | $-1.1B |